3 UK Penny Stocks With Market Caps Below £200M To Consider

In This Article:

The UK market has been flat over the last week, but it is up 10% over the past year, with earnings expected to grow by 14% annually. The term 'penny stocks' might feel like a relic of past market eras, but they continue to offer potential for investors seeking affordability and growth. These stocks typically refer to smaller or newer companies that can provide an underappreciated chance for growth when paired with strong financials.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

Tristel (AIM:TSTL)

£3.975

£190.6M

★★★★★★

ME Group International (LSE:MEGP)

£2.10

£794.96M

★★★★★★

Next 15 Group (AIM:NFG)

£4.05

£404.29M

★★★★☆☆

Supreme (AIM:SUP)

£1.525

£176.67M

★★★★★★

FRP Advisory Group (AIM:FRP)

£1.29

£302.86M

★★★★★★

Stelrad Group (LSE:SRAD)

£1.51

£196.12M

★★★★★☆

Luceco (LSE:LUCE)

£1.474

£229.49M

★★★★★☆

Ultimate Products (LSE:ULTP)

£1.39

£121.5M

★★★★★★

Serabi Gold (AIM:SRB)

£0.906

£70.43M

★★★★★★

Integrated Diagnostics Holdings (LSE:IDHC)

$0.464

$265.96M

★★★★★★

Click here to see the full list of 467 stocks from our UK Penny Stocks screener.

Let's dive into some prime choices out of the screener.

ActiveOps

Simply Wall St Financial Health Rating: ★★★★★★

Overview: ActiveOps Plc provides hosted operations management software as a service solution across various industries in Europe, the Middle East, India, Africa, North America, and Asia Pacific, with a market cap of £90.99 million.

Operations: ActiveOps generates revenue through its Software as a Service (SaaS) offerings, contributing £23.79 million, and Training & Implementation services, which add £2.99 million.

Market Cap: £90.99M

ActiveOps, with a market cap of £90.99 million, has shown financial stability and growth potential as a penny stock. The company became profitable this year, with revenues from SaaS offerings (£23.79 million) and Training & Implementation services (£2.99 million). It is debt-free, with short-term assets exceeding both short-term and long-term liabilities. Revenue is forecasted to grow by 7.97% annually despite earnings expected to decline by 4% over the next three years. Recent board changes aim to enhance leadership depth and US market expertise, potentially supporting future strategic initiatives in financial services and healthcare sectors.

AIM:AOM Debt to Equity History and Analysis as at Oct 2024
AIM:AOM Debt to Equity History and Analysis as at Oct 2024

Intelligent Ultrasound Group

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Intelligent Ultrasound Group plc develops, markets, and distributes medical training simulators globally, with a market cap of £37.22 million.